Pictet Asset Management (UK)’s Axsome Therapeutics AXSM Stock Holding History

Pictet Asset Management (UK)’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$33.4M	Sell	494,782 -120,541	-20%	-$7.23M	0.04%	421
2021 Q1	$34.8M	Sell	615,323 -240,913	-28%	-$16.9M	0.04%	404
2020 Q4	$69.8M	Sell	856,236 -34,323	-4%	-$2.57M	0.09%	252
2020 Q3	$63.5M	Buy	890,559 +94,333	+12%	+$7.35M	0.1%	242
2020 Q2	$65.5M	Buy	796,226 +347,231	+77%	+$26.7M	0.11%	218
2020 Q1	$26.4M	Buy	448,995 +310,963	+225%	+$25.3M	0.06%	315
2019 Q4	$14.3M	Buy	+138,032	New	+$5.57M	0.03%	507

Other funds holding AXSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Pictet Asset Management (UK)'s AXSM Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Axsome Therapeutics (AXSM) stake by 20% in Q2 2021, selling an estimated $7.23M and leaving 494,782 shares worth $33.4M. The position accounts for 0.04% of the portfolio, ranked #421.

Pictet Asset Management (UK) first reported a position in AXSM in Q4 2019 and has held it in 7 quarters since. The position peaked at $69.8M in Q4 2020. 176 funds tracked by Wall St. Rank hold AXSM as of Q2 2021.

Pictet Asset Management (UK) held 494,782 shares of Axsome Therapeutics worth $33.4M as of Q2 2021.
Pictet Asset Management (UK) sold 120,541 Axsome Therapeutics shares in Q2 2021, an estimated $7.23M.
Axsome Therapeutics made up 0.04% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #421 holding.
Pictet Asset Management (UK) first reported a position in Axsome Therapeutics in Q4 2019 and has held it in 7 quarters since.
Pictet Asset Management (UK)'s Axsome Therapeutics position peaked at $69.8M in Q4 2020.
176 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.